LIMITED COMPETING CONTINUATION COOPERATIVE AGREEMENT  DA-95-006 -MAXIMIZING EFFICACY OF PSYCHOTHERAPY



NIH GUIDE, Volume 24, Number 1, January 13, 1995



RFA:  DA-95-006



P.T. 34



Keywords:

  Psychotherapy 

  Drugs/Drug Abuse 



National Institute on Drug Abuse



Application Receipt Date:  January 18, 1995



PURPOSE



The National Institute on Drug Abuse (NIDA) has supported for the

past four to five years a cooperative agreement with a coordinating

center and four sites.  The cooperative agreement was issued under

the announcement entitled, "Maximizing the Efficacy of Psychotherapy

and Drug Abuse Counseling Strategies in the Treatment of Cocaine

Abusers," (RFA #DA-90-01) published in the NIH Guide in January 1990.

Grants to the coordinating center and one site were awarded in FY

1990, and three grants were awarded to three additional sites in FY

1991.  The project is designed to compare the efficacy of four

treatments for cocaine abuse:  group therapy, individual drug

counseling, individual supportive-expressive therapy, and individual

cognitive therapy (the latter three in combination with group

therapy).  In addition, the study will examine the interaction of

patients characteristics (such as psychiatric severity or sociopathy)

with type of psychotherapy/counseling.  Because the project is

ongoing but has not been completed, NIDA is soliciting competing

continuation applications from the CURRENT grantees ONLY.  NO OTHER

APPLICATIONS WILL BE CONSIDERED.  The applications must be directed

to completing the existing research protocols established under the

current cooperative agreement; proposals for new research in addition

to the existing protocols are not acceptable.



The total project period for applications submitted in response to

the present solicitation may not exceed three years.  The anticipated

award date is September 1, 1995.



The completed original application and three copies must be sent or

delivered to:



Division of Research Grants

National Institutes of Health

Westwood Building, Room 240

Bethesda, MD  20892**



An additional two copies must be sent or delivered to:



Mrs. Eleanor C. Friedenberg

Director, Office of Extramural Program Review

National Institute on Drug Abuse

5600 Fishers Lane, Room 10-42

Rockville, MD  20857



INQUIRIES



Additional information may be obtained by contacting:



John Boren, Ph.D.

Division of Clinical and Services Research

National Institute on Drug Abuse

5600 Fishers Lane, Room 10A-30

Rockville, MD  20857

Telephone:  (301) 443-0107

Email:  jboren@aoada.ssw.dhhs.gov



.

Return to 1995 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.